UnknownNot Applicable

Heavy Menstrual Bleeding and Iron Deficiency Anemia

300 participantsStarted 2024-05-01

Plain-language summary

In the present study, we test the ability of AMSS as a simple tool to identify women with HMB who have ID/ IDA. We will compare the AMSS score to patients' hemoglobin and serum ferritin in women with self-reported HMB and women with normal menstrual flow.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Reproductive age women, above age of 18 years old. Exclusion Criteria: * women with amenorrhea, postmenopausal women, current or past (in last 6 months) users of hormonal contraceptives, women who have delivered in the past year, or breast fed in past 6 months are all excluded from the study

What they're measuring

Evaluating the Arabic version of Aberdeen Menorrhagia Severity Scale (AMSS) for prediction of iron deficiency/ iron deficiency anemia in women with the symptom of chronic heavy menstrual bleeding (HMB)

Timeframe: baseline

Trial details

NCT IDNCT05079815

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-05-01

Contact for this trial

Ebraam faiez, bachelor

01095846886 berofaiez@yahoo.com

View on ClinicalTrials.gov More Heavy Menstrual Bleeding trials